Your (e.g., long-term stability vs. short-term growth)?
Strategy: Actively managed by Cathie Wood's team, targeting "disruptive" innovation . Expense Ratio: 0.75% . Comparison of Key Metrics 1-Year Return Expense Ratio Small/Mid-Cap Equal Weight IBB Large-Cap Market Weighted SBIO Clinical Trial Breakthroughs IBBQ Nasdaq Biotech Index Data based on recent 2026 market reports . best biotech etf to buy now
7 Best Biotech ETFs to Buy Now | Investing - U.S. News Money Your (e
Your (e.g., comfortable with high volatility)? Your investment timeframe ? Expense Ratio: 0
The best biotech ETF to buy depends on your risk tolerance: the offers high-growth potential through an equal-weighted approach to smaller firms , while the iShares Biotechnology ETF (IBB) provides stability by focusing on large-cap industry leaders . Top Biotech ETFs to Buy Now SPDR S&P Biotech ETF (XBI) Best for: Aggressive growth and small-cap exposure .
Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure .
Best for: Concentrated exposure to the 25 largest, most liquid biotech stocks . Strategy: Focuses on profitable blue-chip biotechs . Expense Ratio: 0.35% .